Northwest Biotherapeutics Inc NWBO

Healthcare Biotechnology

Northwest Biotherapeutics, Inc. is a biotechnology company. The Company is focused on developing personalized immune therapies for cancer. It has developed a platform technology, DCVax, which uses activated dendritic cells to mobilize a patient's own immune system to attack their cancer. The Company's product line includes DCVax-L and DCVax-Direct. DCVax-L is designed to treat solid tumor cancers in which the tumors can be surgically removed. It has completed a 331-patient international Phase III trial of DCVax-L for Glioblastoma multiforme brain cancer (GBM). DCVax-Direct, is designed to treat inoperable solid tumors. A 40-patient Phase I trial has been completed and included treatment of a diverse range of more than a dozen types of cancers. The Company’s wholly owned subsidiaries include Flaskworks, LLC, Northwest Biotherapeutics Limited, Aracaris Capital, Ltd, Northwest Biotherapeutics B.V., and NW Bio GmbH.

OTCQB:NWBO - Post by User

Northwest Biotherapeutics Inc

Bullboard Posts

Comment by auagmaniacon Jul 09, 2007 7:00pm

122 Views

Post# 13060620

RE: YEEEEEEEHAAAAAAWWWWWWW!!!

Funny thing today....4.35 MILLION SHARES EXIST and nearly 4 MILLION traded. Mine Did NOT trade. I'm holding tight to these babies! I've been in this stock for a year, ups and downs. I just had a deep-seated feeling they'd pull it off. First Switzerland, then the EU!!! That should provide some serious afterburner. Wonder how high she can fly?? It's nice making the $$, but best thing is, looks like this stuff will actually work!!! Godsend if you got a need for it. Hope we can bust over $10.00, so the big funds will look at it. Maybe an AMEX listing would be in order??

Bullboard Posts

Cross border trading in Canada and Australia